深静脉血栓后血栓后综合征的危险与保护因素
该回顾性研究纳入579例深静脉血栓患者,发现71%发生血栓后综合征,其中81%为轻度。复发DVT和恶性肿瘤是危险因素,抗血小板和他汀类降脂治疗是保护因素;多变量分析后仅复发DVT为独立危险因素,降脂治疗为独立保护因素。
要点
- 复发DVT是血栓后综合征的独立危险因素。
- 他汀类降脂治疗是血栓后综合征的独立保护因素。
- 多数血栓后综合征为轻度,平均Villalta评分5.79。
核心结论
- 降脂治疗可能减少血栓后改变。
研究设计与样本
- 回顾性研究纳入2002年1月至2018年6月确诊的579例DVT患者,均接受抗凝和弹力袜治疗,并在3-6个月及每年进行临床和双功超声评估。
主要发现
- 414例(71%)发生PTS,其中337/414(81%)为轻度,平均Villalta评分5.79。
- 单变量分析显示复发DVT(P=.001)和恶性肿瘤(P=.001)为危险因素,抗血小板治疗(P=.049)和他汀类降脂治疗(P=.001)为保护因素。
- 多变量分析后仅复发DVT(P=.001)为独立危险因素,降脂治疗(P=.001)为独立保护因素。
临床怎么用
- 对DVT患者应重视复发预防,并考虑他汀类降脂治疗以降低PTS风险。
局限性
- 回顾性设计可能引入偏倚;未报告具体降脂药物剂量和疗程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The most frequent complication of deep venous thrombosis (DVT) is post-thrombotic syndrome (PTS). We recently showed inhibition of varicose vein development by atorvastatin and rosuvastatin. The aim of this study was to test the influence of lipid-lowering therapy with statins on PTS development. METHODS: All patients between January 2002 and June 2018 with diagnosed DVT were enrolled in this study and analyzed retrospectively. Documentation was performed using the standardized system M1 (CompuGroup Medical, Koblenz, Germany) throughout the observation period. Patients received therapeutic anticoagulation and compression stockings. In case of recurrent DVT, patients received lifelong therapeutic anticoagulation. All patients received clinical examination and duplex ultrasound evaluation 3 to 6 months after primary diagnosis and annually thereafter. RESULTS: A total of 579 patients with DVT were enrolled in this study. Of these patients, 414 (71%) developed PTS (337/414 [81%] presented with the mild version; mean Villalta score, 5.79). Risk factors for PTS development were recurrent DVT (P = .001) and malignant disease (P = .001). Protective factors were therapy with platelet aggregation inhibitors (P = .049) and lipid-lowering therapy with statins (P = .001). After multivariable analysis, the only risk factor was recurrent DVT (P = .001), and the only protective factor was lipid-lowering therapy (P = .001). CONCLUSIONS: Post-thrombotic changes might be reduced by lipid-lowering therapy.
引用
- Cucuruz B, Kopp R, Pfister K, et al. Risk and protective factors for post-thrombotic syndrome after deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31843481. doi:10.1016/j.jvsv.2019.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。